Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 Outcome of Annual Shareholders' Meeting 2020/03/20 HANALL BIOPHARMA CO.,LTD
9 Reporting reasons for holding general shareholders' meeting on the most concentrated date 2020/03/05 HANALL BIOPHARMA CO.,LTD
8 Decision on Calling Shareholders' Meeting 2020/03/03 HANALL BIOPHARMA CO.,LTD
7 Submission of Audit Report 2020/02/26 HANALL BIOPHARMA CO.,LTD
6 Implementation and Operation of Compliance Program of the Fair Trade Commission 2020/02/03 HANALL BIOPHARMA CO.,LTD
5 [Revised]An Explanation for Rumors or Media Reports 2020/01/22 HANALL BIOPHARMA CO.,LTD
4 An Explanation for Rumors or Media Reports 2020/01/22 HANALL BIOPHARMA CO.,LTD
3 Designation of overheated short-selling issues (applied by a restriction on short-selling) 2020/01/21 HANALL BIOPHARMA CO.,LTD
2 30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) 2020/01/16 HANALL BIOPHARMA CO.,LTD
1 Interim Report on Business Performance(Fair Disclosure) 2020/01/16 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
2 2018 Statement of financial position 2019-03-22
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31